Community/Retail

The FDA recently approved 2 new antibiotic combinations targeting resistant Gram-negative organisms.

There's no guessing which team retired pharmacist Irving Rider is rooting for this March Madness.

The FDA today authorized the use of the first device approved to treat dialysis-related amyloidosis.

Sagent Pharmaceuticals is voluntarily recalling 6 lots of its atracurium besylate injection following FDA observations of practices at the manufacturer's site that could potentially affect the products' sterility.

The expansion now includes +6.00D to -9.00D (0.25D steps), helping to make BiotrueONEday for Presbyopia contact lenses available to more multi-focal patients throughout the most common power ranges.

After years of debate and regulatory hurdles, a milestone was achieved today when the FDA approved the first biosimilar in the United States.

Pharmacists are providing collaborative pharmacy services, but lack formal recognition.

Tweeting about quitting may help smokers actually kick the habit.

Ludy L. Underwood, Cardinal Health sales manager for retail/alternative care, pharmaceutical division, talks areas commonly overlooked when pharmacists evaluate cost-savings strategies.

Marc C. Thompson, executive coach and best-selling author, talks about what pharmacists can do to introduce new ideas to a previously unengaged staff.

Two University of Tennessee Health Science Center College of Pharmacy alumni are giving back to their school in a big way.

Arrowhead Research Corporation announced the acquisition of Novartis' entire RNAi research and development portfolio and associated assets.

In light of misrepresented statistics and overstated fears about statin-related adverse events, here are 3 of the biggest myths your patients may have heard about these life-saving medications-and the facts

Bayer HealthCare is suspending enrollment into a Phase III trial with regorafenib (Stivarga) in colorectal cancer patients with resected liver metastases due to insufficient patient recruitment.

A man from Virginia has pleaded guilty to first-degree murder of a pharmacist.

Low testosterone can keep patients from feeling their best. Here's how to help.

Since patients with Barrett's esophagus seem to progress to cancerous stages faster than others, health care professionals might perceive that controlling acid reflux would prevent the transition.

A poorly written résumé can lead to missed job opportunities. Learn how to avoid several all-too-common mistakes.

Taking an antidepressant used in smoking cessation for an extended period of time prior to quitting may help smokers achieve their goal.

Beyond working in traditional retail, community, and health-system settings, pharmacy students have a lot of options. Two Roosevelt University pharmacy students are proof of that.

Members of Roosevelt University's first College of Pharmacy graduating class who took the North American Pharmacist Licensure Exam (NAPLEX) in 2014 did better as a group in passing the exam than the overall pool of candidates that took the NAPLEX last year.

I distinctly remember feeling surprised when the FDA approved the first single entity and extended-release hydrocodone pain medication.

The FDA announced today that it has expanded the indication of Bristol-Myers Squibb's anticancer medication nivolumab (Opdivo) to include the treatment of patients with metastatic squamous non-small cell lung cancer with progression on or after platinum-based chemotherapy.

With the wide selection of available inhalers, this article sheds light on factors that can influence COPD treatment success.

The planned studies include a multicenter, open-label Phase 1b/2 study of lenvatinib plus pembrolizumab in select solid tumors and an open-label, single-arm, multicenter Phase 1b/2 study to evaluate the efficacy and safety of eribulin in combination with pembrolizumab in metastatic triple-negative breast cancer.

The Supreme Court of the United States today heard oral arguments in King v. Burwell, a case that could make the 2010 Affordable Care Act unworkable in most states by eliminating premium subsidies for 7.5 million Americans